Introduction Integrated knowledge regarding pre‐exposure prophylaxis (PrEP) awareness
and willingness to use PrEP can be useful for HIV prevention in high incidence groups. This …

Pre-exposure prophylaxis (PrEP) is an effective form of Human Immunodeficiency Virus
(HIV) prevention for people at potential risk for exposure. Despite its demonstrated efficacy …

A profilaxia pré-exposição sexual (PrEP) tem sido considerada estratégica e promissora no
controle da epidemia de HIV globalmente. Contudo, faz-se necessário transpor o …

People who inject drugs (PWID) experience sexual and injection-related HIV risks, but
uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among PWID has been low …

Introduction: Research has begun to examine human immunodeficiency virus (HIV)
prevention strategies within the Ghanaian context. Still, little is known about specific …

Background: HIV disproportionally affects key populations including men who have sex with
men (MSM). HIV prevalence among MSM varies from 17% in Brazil and Mexico to 13% in …

HIV prevalence among cisgender female sex workers (FSW) and/or women who use drugs
(WWUD) is substantially higher compared to similarly aged women. Consistent with PRISMA …

Introduction There is emerging data on HIV‐1 incidence among MSM in sub‐Saharan Africa
(SSA), but no known estimate of HIV‐1 incidence among transgender women (TGW) in the …

Alternatives to daily dosing of HIV pre-exposure prophylaxis (PrEP) are continuing to
emerge. From October 2019 to March 2020, we conducted an online survey of PrEP …

Pre-exposure prophylaxis (PrEP) is an effective biomedical strategy for HIV prevention. This
umbrella review is aimed at providing a comprehensive summary of the current status of …